Chapter 16: Gastrointestinal Tract Pathology

Loading audio…

ⓘ This audio and summary are simplified educational interpretations and are not a substitute for the original text.

If there is an issue with this chapter, please let us know → Contact Us

A significant portion focuses on the progression from Gastrointestinal Reflux Disease (GERD) to Barrett esophagus, highlighting the metaplastic shift that predisposes patients to adenocarcinoma, as opposed to squamous cell carcinoma linked to smoking and alcohol. Gastric disorders are examined in depth, including congenital pyloric stenosis, Menetrier disease, and the differentiation between acute stress-induced gastritis and chronic gastritis caused by autoimmunity or Helicobacter pylori. The text elaborates on the pathogenesis of peptic ulcer disease and classifies gastric carcinomas into intestinal and diffuse types, the latter characterized by signet-ring cells and linitis plastica. Moving to the intestines, the summary explains mechanical obstructions like volvulus, intussusception, and the aganglionic nature of Hirschsprung disease. Malabsorption syndromes are categorized, with specific emphasis on the immunological basis of Celiac disease and the infectious etiology of Whipple disease. A major section compares the distinct features of Inflammatory Bowel Disease (IBD), contrasting the transmural, skip-lesion presentation of Crohn's disease with the continuous, mucosal inflammation of Ulcerative Colitis. Additional topics include vascular pathologies like ischemic bowel disease and angiodysplasia, as well as Clostridium difficile-associated pseudomembranous colitis. The chapter also outlines the clinical features of Meckel diverticulum and colonic diverticulosis before transitioning to colorectal neoplasia. This includes a detailed breakdown of polyp types, distinguishing neoplastic adenomas from non-neoplastic hamartomas, and a review of hereditary syndromes such as Familial Adenomatous Polyposis (FAP), Gardner syndrome, Turcot syndrome, and Lynch syndrome (HNPCC). The discussion concludes with the molecular pathways of colorectal adenocarcinoma, TNM staging, and the systemic effects of neuroendocrine carcinoid tumors.